Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00386555
Recruitment Status : Withdrawn (Study was cancelled before patient enrollment)
First Posted : October 11, 2006
Last Update Posted : August 9, 2012
Sponsor:
Information provided by:
Arog Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Primary Completion Date : No date given
Study Completion Date : No date given